Stroke Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are already enrolled in the CAPTIVA trial, which involves having had a mild stroke caused by a significant narrowing (70–99%) of a specific artery in the brain, within the last 30 days
- People who are able to have a baseline MRI scan done within 14 days of joining the CAPTIVA trial
Who may not be able to join:
- People who are unable or unwilling to have an MRI scan, including those with a pacemaker or other conditions that make MRI unsafe according to American College of Radiology guidelines
- People who have an allergy to gadolinium contrast dye (a substance used in some MRI scans), or who have kidney disease where the kidneys are not functioning well enough (confirm with trial site for specific kidney function threshold)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: David Liebeskind, MD, University of California, Los Angeles
Phone: 801-585-7575
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Establish ICAS hemodynamic and plaque MRI biomarkers as reliable predictors of recurrent ischemic stroke in the vascular territory of the index stroke.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.